Home
/
ImageneBio, Inc.
/
Financials
/
Quarterly
ImageneBio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ImageneBio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$800.0K
Nov 12, 2025
Q3
2025
Sep 30, 2024
$3.50M
Nov 12, 2025
Q3
2024
Sep 30, 2023
$1.19M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$2.00M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$5.31M
May 13, 2024
Q3
2023
Sep 30, 2022
$6.40M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$382.0K
Aug 10, 2023
Q1
2023
Mar 31, 2022
$3.38M
May 15, 2023
Q3
2022
Sep 30, 2021
$3.75M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$3.55M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$3.47M
May 12, 2022
Q3
2021
Sep 30, 2020
$2.83M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$3.07M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$3.23M
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($24.78M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($7.59M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($2.77M)
Jul 24, 2025
Q1
2025
Mar 31, 2025
($8.62M)
May 8, 2025
Q2
2025
Mar 31, 2025
($8.62M)
Jul 24, 2025
Q3
2025
Mar 31, 2025
($6.08M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($3.18M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($13.73M)
Jul 24, 2025
Q3
2025
Jun 30, 2024
($6.26M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($16.15M)
Jul 24, 2025
Q1
2025
Mar 31, 2024
($16.15M)
May 8, 2025
Q3
2025
Mar 31, 2024
($22.31M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($17.34M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($17.12M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($17.12M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($14.22M)
May 13, 2024
Q3
2024
Mar 31, 2023
($14.22M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($14.22M)
Aug 8, 2024
Q3
2023
Sep 30, 2022
($17.34M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($20.49M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($26.59M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($8.75M)
Jul 24, 2025
Q1
2025
Mar 31, 2025
($10.79M)
May 8, 2025
Q3
2025
Sep 30, 2024
($2.04M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($15.82M)
Jul 24, 2025
Q1
2025
Mar 31, 2024
($18.23M)
May 8, 2025
Q3
2024
Sep 30, 2023
($19.50M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($18.49M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($15.52M)
May 13, 2024
Q3
2023
Sep 30, 2022
($17.88M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($20.95M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($16.96M)
May 15, 2023
Q3
2022
Sep 30, 2021
($14.52M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($12.69M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($9.72M)
May 12, 2022
Q3
2021
Sep 30, 2020
($6.23M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($5.06M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($7.18M)
May 13, 2021